TETRAHYDROCURCUMIN

A major bioactive metabolite of curcumin with superior bioavailability and enhanced antioxidant activity, exhibiting potent anti-inflammatory, hepatoprotective, and skin-lightening properties.

Tetrahydrocurcumin (THC) is a major metabolite of curcumin with enhanced bioavailability, water solubility, and chemical stability compared to its parent compound. It exerts potent antioxidant, anti-inflammatory, and neuroprotective effects by reducing oxidative stress, modulating inflammatory pathways, and protecting mitochondrial function. THC has demonstrated therapeutic potential for cardiovascular health, metabolic dysfunction, neurodegenerative diseases, and age-related conditions.

Reconstitution Calculator

Reconstitution Calculator

Calculate your peptide dosing

Draw Volume
0.100mL
Syringe Units
10units
Concentration
2,500mcg/mL
Doses / Vial
20doses
Vial Total
5mg
Waste / Vial
0mcg
Syringe Cap.
100units · 1mL
How to reconstitute
Gather & prepare
1/6Gather & prepare

Set up a clean workspace with all supplies ready.

1.Wash hands thoroughly, put on disposable gloves
2.Your 5mg peptide vial (lyophilized powder)
3.Bacteriostatic water (you'll need 2mL)
4.A 3–5mL syringe with 21–25 gauge needle for reconstitution
5.Alcohol swabs (70% isopropyl)
Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Sterile water is only safe for single-use.
Supply Planner

7x / week for weeks

·
40%
2vials
28 doses20 days/vial12 leftover
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month
Store 2-8°C30 day shelf lifeSwirl gentlyFor research purposes only

Research

Reported Effects

Enhanced Bioavailability:: Demonstrated 2-3 fold better absorption compared to standard curcumin in multiple studies. Dose-Dependent Effects:: Both upregulation and downregulation of certain enzymes depends on concentration used. Superior Stability:: Greater water solubility and chemical stability compared to curcumin while maintaining therapeutic benefits. Metabolite Advantage:: Acts as an active metabolite of curcumin with similar or enhanced biological activities

  • Demonstrated 2-3 fold better absorption compared to standard curcumin in multiple studies
  • Both upregulation and downregulation of certain enzymes depends on concentration used
  • Greater water solubility and chemical stability compared to curcumin while maintaining therapeutic benefits
  • Acts as an active metabolite of curcumin with similar or enhanced biological activities

Safety Profile

Safety Profile: Tetrahydrocurcumin

Common Side Effects

  • Generally well tolerated at typical doses (250–500 mg/day); better bioavailability than curcumin
  • Mild gastrointestinal symptoms including nausea, bloating, and diarrhea
  • Mild headache reported in some users
  • Yellow discoloration of stools (harmless, related to curcuminoid metabolism)

Serious Adverse Effects

  • Limited human clinical trial data compared to parent compound curcumin; most safety data extrapolated from curcumin studies
  • Potential antiplatelet activity may increase bleeding risk at high doses
  • Theoretical risk of iron chelation and reduced iron absorption with chronic high-dose use
  • No significant hepatotoxicity or nephrotoxicity reported at standard doses in available studies
  • Rare allergic reactions in individuals sensitive to turmeric or Curcuma species

Contraindications

  • Known allergy to turmeric, curcumin, or related Zingiberaceae family plants
  • Active bleeding disorders or upcoming surgery (discontinue 2 weeks prior)
  • Bile duct obstruction or gallstones (curcuminoids stimulate bile flow)
  • Iron deficiency anemia (may impair iron absorption)
  • Pregnancy and lactation (insufficient safety data at supplemental doses; culinary turmeric use is generally safe)

Drug Interactions

  • Anticoagulants/Antiplatelets (warfarin, aspirin, clopidogrel): May potentiate anticoagulant effects; monitor INR and bleeding signs
  • Antidiabetic agents: May enhance hypoglycemic effects; monitor blood glucose
  • CYP3A4 and CYP2C9 substrates: Curcuminoids may inhibit these enzymes; caution with drugs having narrow therapeutic indices
  • Iron supplements: May chelate iron and reduce absorption; separate dosing by at least 2 hours
  • Chemotherapy agents: May interact with certain chemotherapeutics; consult oncologist before concurrent use

Population-Specific Considerations

  • Elderly: Generally well tolerated; monitor for GI side effects and potential drug interactions
  • Pediatric: No established safety data at supplemental doses; not recommended for children
  • Diabetic patients: Monitor blood glucose closely due to potential hypoglycemic effects
  • Gallbladder disease: Avoid use due to choleretic (bile-stimulating) effects
  • Anemic patients: Monitor iron status with long-term use

Pharmacokinetic Profile

Molecular Structure

2D Structure
TETRAHYDROCURCUMIN molecular structure
Molecular Properties
Formula
C21H24O6
Weight
372.4 Da
PubChem CID
124072
Exact Mass
372.1573 Da
LogP
2.8
TPSA
93.1 Ų
H-Bond Donors
2
H-Bond Acceptors
6
Rotatable Bonds
10
Complexity
437
Identifiers (SMILES, InChI)
InChI
InChI=1S/C21H24O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,24-25H,3-4,7-8,13H2,1-2H3
InChIKeyLBTVHXHERHESKG-UHFFFAOYSA-N

Safety Profile

Common Side Effects

  • Trace Mineral Depletion:: Potential for zinc, copper, and selenium depletion with long-term curcuminoid use based on NAC-related reports
  • Digestive Interactions:: Can affect pepsin function and enzyme activity in concentration-dependent manner
  • Limited Human Data:: Most safety profiles derived from animal studies with minimal long-term human clinical data
  • Generally Well-Tolerated:: No major adverse effects reported in animal studies at therapeutic doses

References (9)

  1. [1]
    Positive Tetrahydrocurcumin-Associated Brain-Related Metabolomic Implications

    THC demonstrates strong antioxidant properties and effectively reduces amyloid β aggregates in various brain dysfunction models including traumatic brain injury, ischemia-reperfusion injury, Alzheimer's disease, and Parkinson's disease.

  2. [2]
    Nutraceutical activation of Sirt1: a review

    Tetrahydrocurcumin is identified as a nutraceutical that enhances Sirt1 synthesis and protein expression, contributing to anti-aging effects and improved healthspan similar to calorie restriction.

  3. [3]
    Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency

    THC at 50-100 mg/kg significantly reduced blood pressure, peripheral vascular resistance, and aortic stiffness while improving oxidative stress markers in hypertensive rats.

  4. [4]
    Tetrahydrocurcumin-Related Vascular Protection: An Overview of the Findings from Animal Disease Models

    THC demonstrates preventive effects on vascular dysfunction and hypertension development through improvements in hemodynamic status, aortic elasticity, and reduction of oxidative stress in various animal models.

  5. [5]
    The role of tetrahydrocurcumin in disease prevention and treatment

    Comprehensive review highlighting THC's important roles in prevention and treatment of various diseases, with enhanced bioavailability compared to curcumin from herbal medicine and dietary sources.

  6. [6]
    Tetrahydrocurcumin Ameliorates Skin Inflammation by Modulating Autophagy in High-Fat Diet-Induced Obese Mice

    THC demonstrated anti-inflammatory and antioxidant effects by modulating autophagy processes in skin tissue of obese mice, addressing obesity-induced chronic low-grade inflammation.

  7. [7]
    Tetrahydrocurcumin Enhances Islet Cell Function and Attenuates Apoptosis in Mouse Islets

    THC treatment enhanced islet cell function and reduced apoptosis before transplantation, demonstrating antioxidant and anti-inflammatory activities that protect against ischemic damage.

  8. [8]
    Tetrahydrocurcumin: effect on chloroquine-mediated oxidative damage in rat kidney

    Oral administration of THC at 80 mg/kg significantly prevented chloroquine-induced nephrotoxicity by decreasing lipid peroxidation and increasing antioxidant levels in kidney tissue.

  9. [9]
    Efficacy of TurmiZn, a Metallic Complex of Curcuminoids-Tetrahydrocurcumin and Zinc on Bioavailability, Antioxidant, and Cytokine Modulation Capability

    A curcuminoid-THC-zinc complex showed 2-3 fold increase in bioavailability compared to curcumin and THC alone, with enhanced antioxidant capability and inflammatory cytokine inhibition.

Updated 2026-03-08Sources: peptidebay, pubchem

On this page